Minkyoung Kim
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Discovery of novel naphthalene-based diarylamides as pan-Raf kinase inhibitors with promising anti-melanoma activity: rational design, synthesis, in vitro and in silico screening.
Journal: Archives of pharmacal research
Published: March 09, 2024
Stilbenoid derivatives as potent inhibitors of HIF-1α-centric cancer metabolism under hypoxia.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 06, 2024
Rational design, synthesis, biological evaluation, and molecular modeling of novel naphthamide derivatives possessing potent, reversible, and competitive inhibitory mode of action over human monoamine oxidase.
Journal: Molecular diversity
Published: December 29, 2023
HIF-1α inhibition by MO-2097, a novel chiral-free benzofuran targeting hnRNPA2B1.
Journal: Journal of advanced research
Published: July 18, 2023
Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 05, 2023
Chemical induction of the interaction between AIMP2-DX2 and Siah1 to enhance ubiquitination.
Journal: Cell chemical biology
Published: January 11, 2023
Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models.
Journal: Journal of medicinal chemistry
Published: November 03, 2020
The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation.
Journal: Experimental & molecular medicine
Published: May 26, 2020
Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy.
Journal: Journal of medicinal chemistry
Published: April 22, 2020
Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization.
Journal: Pharmaceutics
Published: March 15, 2019
Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development.
Journal: Nature chemical biology
Published: March 04, 2019
Last Updated: 09/26/2026